DAIICHI SANKYO COMPANY,LIMITED

4568 TSE Pharmaceuticals Pharmaceutical
TSE Prime
¥2,772.00
+2.33%
Delayed · cached 15 min

Fair value analysis

4568
DAIICHI SANKYO COMPANY,LIMITED
PharmaceuticalsPharmaceutical
¥2,772.00
Close used for this calculation
¥2,711.01Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
53/100
Profitability21/25
Returns11/25
Balance Sheet7/25
Efficiency14/25
Growth15/25
Good
Quality radar
53Prof.21/25Ret.11/25Eff.14/25B.Sht7/25Growth15/25

Consensus fair value

¥2,711.01
Near FV
▼ -2.2% against the close used
Model range ¥1,385.96 – ¥4,213.20
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear¥1,385.96Fair value¥2,711.01Bull¥4,213.20
FairClose
52-week traded range
52W low ¥2,392.0052W high ¥4,174.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading close to the consensus fair value

DAIICHI SANKYO COMPANY,LIMITED closed at ¥2,772.00, 2.2% above the consensus fair value of ¥2,711.01 drawn from 9 valuation models.

Financial DNA score 53/100 — Good. P/E of 19.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
¥2,787.60
+0.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
¥1,385.96
-50.0%
√(22.5 × EPS × BVPS)
EPS=140.44, BVPS=607.89 · outside Graham range (P/E 19.7, P/B 4.6) — asset-light, treat as a rough floor
P/E Fair Value
¥2,808.80
+1.3%
EPS × 20x (sector P/E)
EPS=140.44, Sector P/E=20x
Peter Lynch (PEG)
¥4,213.20
+52.0%
EPS × Growth% (PEG = 1 is fair)
EPS=140.44, g=30%
EV/EBITDA
¥2,657.44
-4.1%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=306.55B
Dividend Discount (DDM)
¥4,206.23
+51.7%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=77.89, r=10%, g=8%
Book Value (P/B)
¥1,489.34
-46.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=607.89, ROE=15.8%, g=6%, r=10%
Reverse DCF
¥2,772.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 7% | Historical: 40.4%
Margin of Safety
¥1,745.59
-37.0%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=2327.45, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.